Terms: = Lymphoma AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Prognosis
39 results:
1. Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.
Ligero-López J; Sánchez-Castellano MÁ; Falces-Romero I; Montero-Vega MD; García-Rodríguez J
J Neurovirol; 2023 Oct; 29(5):598-604. PubMed ID: 37470903
[TBL] [Abstract] [Full Text] [Related]
2. Pathology for severe inflammatory pml with PD1/PD-L1 expression of favorable prognosis: What's a prognostic factor for pml-IRIS?
Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
[TBL] [Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
Diamantopoulos PT; Kalopisis K; Tsatsou A; Efthymiou A; Giannakopoulou N; Hatzidavid S; Viniou NA
Eur J Haematol; 2022 May; 108(5):359-368. PubMed ID: 35100451
[TBL] [Abstract] [Full Text] [Related]
4. A case of intravascular large B cell lymphoma with brain involvement mimicking progressive multifocal leukoencephalopathy.
Belli E; Milano C; Pesaresi I; Trivelli I; Tavoni A; Ciancia E; Alì G; Zampa V; Pizzanelli C; Siciliano G; Ricci G
Int J Neurosci; 2023 Jul; 133(7):735-739. PubMed ID: 34425062
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
[TBL] [Abstract] [Full Text] [Related]
6. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
[TBL] [Abstract] [Full Text] [Related]
7. [Expressing of linc-223 and miR-125a in Patients with Acute Leukemia and Its Clinical Significance].
Liu AF; Chen YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1819-1825. PubMed ID: 33283704
[TBL] [Abstract] [Full Text] [Related]
8. Ibrutinib treatment of mantle cell lymphoma complicated by progressive multifocal leukoencephalopathy
.
Mosna K; Ladicka M; Drgona L; Vranovska M; Hojsikova I; Tomasova R; Danihel L; Kyselovic J; Babal P
Int J Clin Pharmacol Ther; 2020 Jun; 58(6):343-350. PubMed ID: 32213285
[TBL] [Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy after CAR T therapy.
Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Significance of bcr-1 and bcr-3 Isoforms of pml-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract] [Full Text] [Related]
12. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
[TBL] [Abstract] [Full Text] [Related]
13. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
14. [Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia].
Zhao XF; Wang HY; Zhao X; Cheng HC; Li W; Liu SW; Qiu L; Ma J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):947-952. PubMed ID: 30111389
[TBL] [Abstract] [Full Text] [Related]
15. Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell transplant - a case series.
Adrianzen Herrera D; Ayyappan S; Jasra S; Kornblum N; Derman O; Shastri A; Mantzaris I; Verma A; Braunschweig I; Janakiram M
Leuk Lymphoma; 2019 Feb; 60(2):395-401. PubMed ID: 29969336
[TBL] [Abstract] [Full Text] [Related]
16. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract] [Full Text] [Related]
17. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/pml-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
[TBL] [Abstract] [Full Text] [Related]
18. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
[TBL] [Abstract] [Full Text] [Related]
19. Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
Poiré X; Moser BK; Gallagher RE; Laumann K; Bloomfield CD; Powell BL; Koval G; Gulati K; Holowka N; Larson RA; Tallman MS; Appelbaum FR; Sher D; Willman C; Paietta E; Stock W
Leuk Lymphoma; 2014 Jul; 55(7):1523-32. PubMed ID: 24160850
[TBL] [Abstract] [Full Text] [Related]
20. Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Michallet AS; Warzocha K; Biliński P; Boyle P; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):165-74. PubMed ID: 23283519
[TBL] [Abstract] [Full Text] [Related]
[Next]
